ABVC BioPharma, Inc. (ABVC) Net income 2017–2025
ABVC BioPharma, Inc. (ABVC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$7.9MFY2025 · since FY2017: -$4.2M → -$7.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.9M | -61.3% |
| FY2024 | -$4.9M | +37.0% |
| FY2023 | -$7.8M | +52.6% |
| FY2022 | -$16.4M | -27.9% |
| FY2021 | -$12.8M | -21.2% |
| FY2020 | -$10.6M | -169.3% |
| FY2019 | -$3.9M | +35.1% |
| FY2018 | -$6.1M | -42.9% |
| FY2017 | -$4.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABVC financial trends
ABVC RevenueABVC Net marginABVC Gross profitABVC Gross marginABVC Operating incomeABVC Operating marginABVC Operating cash flowABVC Free cash flowABVC Capital expendituresABVC Return on equityABVC Stock buybacksABVC Dividends paidABVC Total assetsABVC Total liabilitiesABVC Shareholders’ equityABVC overview →